SAM
HZNP

Securian Asset Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Securian Asset Management’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-82,026
Closed -$1.01M – 1005
2014
Q3 		$1.01M Buy
+82,026
New +$953K 0.03% 449

Other funds holding HZNP

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

Securian Asset Management's HZNP Position: Q4 2014 in Review

Securian Asset Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2014, closing a stake of 82,026 shares — an estimated $1.01M sold.

Securian Asset Management first reported a position in HZNP in Q3 2014 and held it in 1 quarter. The position peaked at $1.01M in Q3 2014. 136 funds tracked by Wall St. Rank hold HZNP as of Q4 2014.

  • Securian Asset Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2014 after selling out during the quarter.
  • Securian Asset Management sold 82,026 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2014, an estimated $1.01M.
  • Securian Asset Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2014 and held it in 1 quarter.
  • Securian Asset Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $1.01M in Q3 2014.
  • 136 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2014.

Based on Securian Asset Management's 13F filing for Q4 2014, filed 4 Feb 2015.